BRCA1 | Breast cancer 1, early onset | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
C1QBP | Complement component 1, q subcomponent binding protein | Cancer-related genes Mitochondrial proteins Plasma proteins Transporters
| | | | | Expressed in all |
C6 | Complement component 6 | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted secreted proteins Transporters
| | | | | Tissue enriched |
CA8 | Carbonic anhydrase VIII | Cancer-related genes Disease related genes
| | | | | Mixed |
CALM1 | Calmodulin 1 (phosphorylase kinase, delta) | Cancer-related genes Disease related genes Plasma proteins Potential drug targets RAS pathway related proteins Transporters
| | | | | Expressed in all |
CALM2 | Calmodulin 2 (phosphorylase kinase, delta) | Cancer-related genes Disease related genes Plasma proteins Potential drug targets RAS pathway related proteins Transporters
| | | | | Expressed in all |
CANX | Calnexin | Cancer-related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CASP10 | Caspase 10, apoptosis-related cysteine peptidase | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
CASP3 | Caspase 3, apoptosis-related cysteine peptidase | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
CASP6 | Caspase 6, apoptosis-related cysteine peptidase | Cancer-related genes Enzymes
| | | | | Expressed in all |
CAT | Catalase | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins
| | | | | Expressed in all |
CAV1 | Caveolin 1, caveolae protein, 22kDa | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CBL | Cbl proto-oncogene, E3 ubiquitin protein ligase | Cancer-related genes Disease related genes
| | | | | Mixed |
CCL21 | Chemokine (C-C motif) ligand 21 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CCNA2 | Cyclin A2 | Cancer-related genes
| | | | | Mixed |
CCNB1 | Cyclin B1 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
CCNB2 | Cyclin B2 | Cancer-related genes Plasma proteins
| | | | | Tissue enhanced |
CCNE2 | Cyclin E2 | Cancer-related genes
| | | | | Mixed |
CCNG1 | Cyclin G1 | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
CCNG2 | Cyclin G2 | Cancer-related genes
| | | | | Expressed in all |
CCR7 | Chemokine (C-C motif) receptor 7 | Cancer-related genes CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
CD14 | CD14 molecule | Cancer-related genes CD markers Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
CD27 | CD27 molecule | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CD36 | CD36 molecule (thrombospondin receptor) | Cancer-related genes CD markers Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
CD38 | CD38 molecule | Cancer-related genes CD markers Enzymes
| | | | | Mixed |
CD40 | CD40 molecule, TNF receptor superfamily member 5 | Cancer-related genes CD markers Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CD40LG | CD40 ligand | Cancer-related genes Candidate cardiovascular disease genes CD markers Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
CD44 | CD44 molecule (Indian blood group) | Blood group antigen proteins Cancer-related genes CD markers FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CD46 | CD46 molecule, complement regulatory protein | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
CD59 | CD59 molecule, complement regulatory protein | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CD74 | CD74 molecule, major histocompatibility complex, class II invariant chain | Cancer-related genes CD markers Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
CD82 | CD82 molecule | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
CD9 | CD9 molecule | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
CDC16 | Cell division cycle 16 | Cancer-related genes
| | | | | Expressed in all |
CDC20 | Cell division cycle 20 | Cancer-related genes Plasma proteins
| | | | | Tissue enhanced |
CDC34 | Cell division cycle 34 | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Expressed in all |
CDC37 | Cell division cycle 37 | Cancer-related genes
| | | | | Expressed in all |
CDC6 | Cell division cycle 6 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Mixed |
CDH1 | Cadherin 1, type 1, E-cadherin (epithelial) | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
CDH17 | Cadherin 17, LI cadherin (liver-intestine) | Cancer-related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
CDK1 | Cyclin-dependent kinase 1 | Cancer-related genes Enzymes Plasma proteins
| | | | | Mixed |
CDK6 | Cyclin-dependent kinase 6 | Cancer-related genes Enzymes Plasma proteins
| | | | | Mixed |
CDK7 | Cyclin-dependent kinase 7 | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
CDKN1C | Cyclin-dependent kinase inhibitor 1C (p57, Kip2) | Cancer-related genes Disease related genes
| | | | | Expressed in all |
CEACAM5 | Carcinoembryonic antigen-related cell adhesion molecule 5 | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
CEACAM6 | Carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen) | Cancer-related genes CD markers Predicted membrane proteins
| | | | | Group enriched |
CFHR1 | Complement factor H-related 1 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CFLAR | CASP8 and FADD-like apoptosis regulator | Cancer-related genes Enzymes
| | | | | Expressed in all |
CFTR | Cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
CGA | Glycoprotein hormones, alpha polypeptide | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |